Correvio: 2Q Earnings Snapshot
VANCOUVER, British Columbia (AP) _ Correvio Pharma Corp. (CORV) on Wednesday reported a second-quarter loss of $10.5 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Vancouver, British Columbia-based company said it had a loss of 26 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The cardiovascular drug maker posted revenue of $7.4 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $7.6 million.
The company’s shares closed at $1.65. A year ago, they were trading at $4.74.